Physician profile
Brian Patrick Kiley
NPI 1225055759
$1,644.06
in general payments reported to CMS, 2019-2025
13 companies · $448 in 2025
The $448 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $157 · 2020: $114 · 2021: $190 · 2022: $200 · 2023: $241 · 2024: $294 · 2025: $448.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $979 · Education: $4.78.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $978.62 |
| Education | $4.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $483.18 | 2024-2025 | Infuse, Miebo, Xiidra |
| Allergan, INC. | $287.08 | 2019-2021 | |
| Coopervision INC. | $278.86 | 2021-2025 | Misight Contact Lens, Myday Contact Lens |
| Abbvie INC. | $183.98 | 2022-2024 | |
| Alcon Vision LLC | $119.08 | 2023-2024 | Rocklatan, Total30 |
| Medline Industries Lp | $81.54 | 2025 | |
| Maculogix, INC. | $77.80 | 2020 | |
| Optovue, INC. | $31.84 | 2021 | |
| Johnson & Johnson Vision Care, INC. | $26.10 | 2020-2024 | |
| Glaukos Corporation | $25.06 | 2020 | |
| Oyster Point Pharma, INC. | $18.80 | 2022 | |
| Novartis Pharmaceuticals Corporation | $16.09 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $14.65 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Kiley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.